Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

E-Pedigree Could Be A Key Law Enforcement Tool, J&J Exec Says

Executive Summary

While much of the discussion surrounding electronic pedigrees and the accompanying track-and-trace technology has been focused on allowing all parts of the supply chain to verify the authenticity of the pharmaceutical products they receive, the data and technology also could be a valuable tool for law enforcement agents

You may also be interested in...



RFID’s Possible Interaction With Biologics Queried By Biogen, Pfizer

Radiofrequency identification appears to hold the most potential to increase the security of the pharmaceutical supply chain, stakeholders advise FDA, but important questions include how the radiofrequency emissions might interact with biologics and certain other kinds of drug products

House Bill Requires Standard Numerical Identifiers For Drug Tracking By 2010

Legislation setting specific deadlines to implement drug tracking requirements was introduced April 17 by Reps. Steve Buyer, R-Ind., and Jim Matheson, D-Utah

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

UsernamePublicRestriction

Register

PS049810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel